November 01, 2017

Recent Developments in Off-Label Use and Legal Implications to Physicians

Natalia Mazina, Klein, Hockel, Iezza & Patel, P.C., San Francisco, CA

The off-label use of prescriptions has come under scrutiny in the past few years and has led to several new developments in 2017 attempting to address the issue. Among such new changes are the Food and Drug Administration’s (FDA’s) modification of what constitutes “intended use” and Arizona’s law allowing manufacturers to communicate off-label uses of their products. 

Premium Content For:
  • Health Law Section
    • ABA Health eSource
Join - Now